<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82297</article-id><article-id pub-id-type="doi">10.7554/eLife.82297</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Differences in the inflammatory proteome of East African and Western European adults and associations with environmental and dietary factors</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-288775"><name><surname>Temba</surname><given-names>Godfrey S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1093-3037</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288776"><name><surname>Vadaq</surname><given-names>Nadira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288777"><name><surname>Kullaya</surname><given-names>Vesla</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6120-3985</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288780"><name><surname>Pecht</surname><given-names>Tal</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47022"><name><surname>Lionetti</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11696"><name><surname>Cavalieri</surname><given-names>Duccio</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288948"><name><surname>Schultze</surname><given-names>Joachim L</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288778"><name><surname>Kavishe</surname><given-names>Reginald</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48613"><name><surname>Joosten</surname><given-names>Leo AB</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6166-9830</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46561"><name><surname>van der Ven</surname><given-names>Andre J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1833-3391</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250207"><name><surname>Mmbaga</surname><given-names>Blandina T</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200873"><name><surname>Netea</surname><given-names>Mihai G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2421-6052</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-45300"><name><surname>de Mast</surname><given-names>Quirijn</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6056-157X</contrib-id><email>quirijn.demast@radboudumc.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05wg1m734</institution-id><institution>Department of Internal Medicine, Radboudumc Center for Infectious Diseases, Radboudumc Research Institute for Medical innovation (RIMI), Radboud University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Nijmegen</named-content></addr-line><country>Netherlands</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04knhza04</institution-id><institution>Department of Medical Biochemistry and Molecular Biology, Kilimanjaro Christian Medical University College</institution></institution-wrap><addr-line><named-content content-type="city">Moshi</named-content></addr-line><country>United Republic of Tanzania</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04knhza04</institution-id><institution>Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Moshi</named-content></addr-line><country>United Republic of Tanzania</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041nas322</institution-id><institution>Department for Genomics and Immunoregulation, Life &amp; Medical Sciences (LIMES) Institute, University of Bonn</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043j0f473</institution-id><institution>Systems Medicine, German Center for Neurodegenerative Diseases (DZNE)</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01n2xwm51</institution-id><institution>Departement NEUROFARBA, University of Florence – Gastroenterology and Nutrition Unit, Meyer Children's Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Florence</named-content></addr-line><country>Italy</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04jr1s763</institution-id><institution>Department of Biology, University of Florence</institution></institution-wrap><addr-line><named-content content-type="city">Florence</named-content></addr-line><country>Italy</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041nas322</institution-id><institution>PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and University of Bonn</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051h0cw83</institution-id><institution>Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy</institution></institution-wrap><addr-line><named-content content-type="city">Cluj-Napoca</named-content></addr-line><country>Romania</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04knhza04</institution-id><institution>Department of Paediatrics, Kilimanjaro Christian Medical University College</institution></institution-wrap><addr-line><named-content content-type="city">Moshi</named-content></addr-line><country>United Republic of Tanzania</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041nas322</institution-id><institution>Department of Immunology and Metabolism, Life &amp; Medical Sciences (LIMES) Institute, University of Bonn</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0176yjw32</institution-id><institution>Universidade Federal de Minas Gerais</institution></institution-wrap><country>Brazil</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Isales</surname><given-names>Carlos</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012mef835</institution-id><institution>Augusta University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>09</day><month>08</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e82297</elocation-id><history><date date-type="received" iso-8601-date="2022-07-29"><day>29</day><month>07</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-08-08"><day>08</day><month>08</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-08-25"><day>25</day><month>08</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.08.23.504992"/></event></pub-history><permissions><copyright-statement>© 2023, Temba et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Temba et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82297-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-82297-figures-v2.pdf"/><abstract><p>Non-communicable diseases (NCDs) are rising rapidly in urbanizing populations in sub-Saharan Africa. Assessment of inflammatory and metabolic characteristics of a urbanizing African population and the comparison with populations outside Africa could provide insight in the pathophysiology of the rapidly increasing epidemic of NCDs, including the role of environmental and dietary changes. Using a proteomic plasma profiling approach comprising 92 inflammation-related molecules, we examined differences in the inflammatory proteome in healthy Tanzanian and healthy Dutch adults. We show that healthy Tanzanians display a pro-inflammatory phenotype compared to Dutch subjects, with enhanced activity of the Wnt/β-catenin signalling pathway and higher concentrations of different metabolic regulators such as 4E-BP1 and fibroblast growth factor 21. Among the Tanzanian volunteers, food-derived metabolites were identified as an important driver of variation in inflammation-related molecules, emphasizing the potential importance of lifestyle changes. These findings endorse the importance of the current dietary transition and the inclusion of underrepresented populations in systems immunology studies.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>inflammation</kwd><kwd>proteome</kwd><kwd>immune system</kwd><kwd>Africa</kwd><kwd>diet</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013279</institution-id><institution>Joint Programming Initiative A healthy diet for a healthy life</institution></institution-wrap></funding-source><award-id>TransMic (project 529051018)</award-id><principal-award-recipient><name><surname>Netea</surname><given-names>Mihai G</given-names></name><name><surname>de Mast</surname><given-names>Quirijn</given-names></name><name><surname>Cavalieri</surname><given-names>Duccio</given-names></name><name><surname>Lionetti</surname><given-names>Paolo</given-names></name><name><surname>Schultze</surname><given-names>Joachim L</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Netea</surname><given-names>Mihai G</given-names></name><name><surname>de Mast</surname><given-names>Quirijn</given-names></name><name><surname>van der Ven</surname><given-names>Andre J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Radboud Revolving Research Funds</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Temba</surname><given-names>Godfrey S</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100019899</institution-id><institution>Ministry of Finance of Republic of Indonesia</institution></institution-wrap></funding-source><award-id>Indonesia Endowment Fund for Education</award-id><principal-award-recipient><name><surname>Vadaq</surname><given-names>Nadira</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id><institution>Netherlands Organisation for Scientific Research</institution></institution-wrap></funding-source><award-id>Spinoza Prize NWO SPI94-212</award-id><principal-award-recipient><name><surname>Netea</surname><given-names>Mihai G</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>Advanced grant 833247</award-id><principal-award-recipient><name><surname>Netea</surname><given-names>Mihai G</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>EXC2151 390873048</award-id><principal-award-recipient><name><surname>Netea</surname><given-names>Mihai G</given-names></name><name><surname>Schultze</surname><given-names>Joachim L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Comparing the inflammatory proteome of healthy Tanzanian and Dutch adults highlights a pro-inflammatory phenotype and metabolic differences in Tanzanians, with the potential role of food-derived metabolites in driving inflammation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The human immune response is tightly regulated by a complex and intricate network of pro-and anti-inflammatory cytokines, chemokines and other immuno-metabolic mediators. Prolonged dysregulation of this network may result in an unresolved pro-inflammatory state, which is central to the development of a wide range of non-communicable diseases (NCDs), including cardiovascular disease, diabetes, rheumatic and inflammatory bowel diseases, and even malignancies (<xref ref-type="bibr" rid="bib8">Choi et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Moore and Tabas, 2011</xref>; <xref ref-type="bibr" rid="bib33">Seyedsadjadi and Grant, 2021</xref>). The inflammatory response is highly variable among healthy individuals as a consequence of genetic and non-genetic factors (<xref ref-type="bibr" rid="bib6">Brodin and Davis, 2017</xref>). These include intrinsic factors such as age and sex, as well as environmental exposures such as diet and past infections (<xref ref-type="bibr" rid="bib24">Liston et al., 2021</xref>). Not surprisingly, variation in inflammatory proteins between populations has been reported (<xref ref-type="bibr" rid="bib32">Schutte et al., 2012</xref>; <xref ref-type="bibr" rid="bib31">Schutte et al., 2006</xref>). Understanding the nature of this variation and the factors involved is key for understanding the dynamics of infectious as well as immune-mediated pathology across populations.</p><p>Worldwide, many communities are currently undergoing a rapid urbanization process with a transition of lifestyle, and diet, characterized by a more sedentary lifestyle and a shift from traditional high-fiber diets to a diet richer in processed foods, animal fat and simple carbohydrates. Also, environmental exposures change from close contact with animals and smoke from burning wood to petrol gasses. This is accompanied by an epidemiologic transition in which the burden of disease shifts from infectious diseases to NCDs (<xref ref-type="bibr" rid="bib3">Beaglehole et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Unwin et al., 2010</xref>). This epidemiologic transition is at least partly mediated through effects on the immune system of individuals across communities. We recently reported that urban-living Tanzanians display a pro-inflammatory gene signature and higher ex-vivo cytokine responses compared to rural-living individuals (<xref ref-type="bibr" rid="bib35">Temba et al., 2021</xref>) and that food-derived metabolites are an important driver of this difference. In communities in sub-Saharan Africa, this effect may also be more pronounced than in other populations, as the historically high burden of infectious diseases may have resulted in the selection of genotypes favoring a robust immune response (<xref ref-type="bibr" rid="bib19">Karlsson et al., 2014</xref>). Indeed, we recently showed important differences in the genetic regulation of cytokine responses between healthy Tanzanian and Dutch individuals, with enrichment of interferon pathways in the Tanzanians (<xref ref-type="bibr" rid="bib5">Boahen et al., 2022</xref>). In a context with a declining burden of infectious diseases, alongside a shift to an unhealthy Western-type lifestyle, such a heritable pro-inflammatory phenotype may particularly drive a health-to-disease transition with the onset of NCDs (<xref ref-type="bibr" rid="bib4">Bickler et al., 2018</xref>).</p><p>Studies on non-Western populations outside historically wealthy countries are underrepresented in systems-immunology literature, despite the fact that these populations are representative of the majority of the world’s population. In addition, these populations offer unique opportunities to increase our understanding of the pathophysiology of NCDs, including the role of diet and environmental exposures. Our present knowledge of the regulation of the immune system in individuals in sub-Saharan Africa and how this compares to individuals in the industrialized world is limited. We investigated the hypothesis that healthy individuals in East Africa have a pro-inflammatory phenotype in comparison to individuals from North-western Europe and that these differences are partly driven by common environmental factors, including diet. Using a 92-plex proteomic panel based on a proximity extension assay technology, we compared the inflammatory proteome of healthy Tanzanians of African origin residing in Tanzania with that of healthy individuals of Western-European ancestry living in the Netherlands. Next, we studied associations between the proteome with intrinsic factors and environmental exposures, with special emphasis on the food-derived metabolites.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Demographics</title><p>Data from plasma samples of 318 Tanzanian and 416 Dutch individuals were included in this study. Characteristics of study participants are summarized in <xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. The Tanzanians had a significantly higher median (IQR) age (30.2 years; 23.4–39.9) than the Dutch (23.0 years; 21.0–26.0; p-value &lt;0.0001) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Tanzanian females also had a higher BMI than Dutch females (25.7; 22.6–29.9 vs. 21.5; 20.4–23.1; p-value &lt;0.0001) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Descriptive characteristics of study participants.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="center" valign="bottom">Tanzanians</th><th align="center" valign="bottom">Dutch</th><th align="center" valign="bottom">p-value</th></tr></thead><tbody><tr><td align="left" valign="bottom">Number</td><td align="center" valign="bottom">318</td><td align="center" valign="bottom">416</td><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sex, females</td><td align="center" valign="bottom">163 (51.3)</td><td align="center" valign="bottom">214 (51.4)</td><td align="center" valign="bottom">ns</td></tr><tr><td align="left" valign="bottom">Age, years</td><td align="center" valign="bottom">30 (23–40)</td><td align="center" valign="bottom">23 (21–26)</td><td align="center" valign="bottom">&lt;0.0001</td></tr><tr><td align="left" valign="bottom"><bold>Age category</bold></td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom">&lt;0.0001</td></tr><tr><td align="char" char="ndash" valign="bottom">18–30 years</td><td align="center" valign="bottom">155 (48.7)</td><td align="center" valign="bottom">351 (85.8)</td><td align="center" valign="bottom"/></tr><tr><td align="char" char="ndash" valign="bottom">31–40 years</td><td align="center" valign="bottom">84 (26.4)</td><td align="center" valign="bottom">15 (3.7)</td><td align="center" valign="bottom"/></tr><tr><td align="char" char="ndash" valign="bottom">41–50 years</td><td align="center" valign="bottom">50 (15.7)</td><td align="center" valign="bottom">4 (1.0)</td><td align="center" valign="bottom"/></tr><tr><td align="char" char="ndash" valign="bottom">50–60 years</td><td align="center" valign="bottom">25 (7.9)</td><td align="center" valign="bottom">13 (3.2)</td><td align="center" valign="bottom"/></tr><tr><td align="char" char="." valign="bottom">≥60 years</td><td align="center" valign="bottom">4 (1.3)</td><td align="center" valign="bottom">26 (6.4)</td><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>BMI</bold></td><td align="center" valign="bottom">23.8 (21.4–27.3)</td><td align="center" valign="bottom">22.3 (20.7–24.3)</td><td align="center" valign="bottom">&lt;0.0001</td></tr><tr><td align="left" valign="bottom">BMI category</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom">&lt;0.0001</td></tr><tr><td align="char" char="." valign="bottom">≤24.9</td><td align="center" valign="bottom">194 (61.0)</td><td align="center" valign="bottom">337 (84.0)</td><td align="center" valign="bottom"/></tr><tr><td align="char" char="ndash" valign="bottom">≥25–29.9</td><td align="center" valign="bottom">76 (23.9)</td><td align="center" valign="bottom">57 (14.2)</td><td align="center" valign="bottom"/></tr><tr><td align="char" char="." valign="bottom">≥30</td><td align="center" valign="bottom">48 (15.1)</td><td align="center" valign="bottom">7 (1.7)</td><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>BMI by sex</bold></td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Male</td><td align="center" valign="bottom">22.8 (20.8–24.9)</td><td align="center" valign="bottom">23 (21.7–24.6)</td><td align="center" valign="bottom">ns</td></tr><tr><td align="left" valign="bottom">Female</td><td align="center" valign="bottom">25.7 (22.6–29.9)</td><td align="center" valign="bottom">21.5 (20.4–23.1)</td><td align="center" valign="bottom">&lt;0.0001</td></tr><tr><td align="left" valign="bottom">Smoking (N, %)</td><td align="center" valign="bottom">50 (15.7)</td><td align="center" valign="bottom">57 (13.7)</td><td align="center" valign="bottom">ns</td></tr><tr><td align="left" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom" colspan="4"><bold>Study characteristics only relevant for the Tanzanian cohort</bold></td></tr><tr><td align="left" valign="bottom">Residency (N, %)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Urban</td><td align="center" valign="bottom">250 (78.6)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Rural</td><td align="center" valign="bottom">68 (21.4)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>Highest level of education (N, %</bold>)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Primary</td><td align="center" valign="bottom">119 (37.4)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Secondary</td><td align="center" valign="bottom">69 (21.7)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">College</td><td align="center" valign="bottom">61 (19.2)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">University</td><td align="center" valign="bottom">25 (7.9)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">In training</td><td align="center" valign="bottom">44 (13.8)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>Occupational status (N, %</bold>)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Student</td><td align="center" valign="bottom">57 (17.9)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Employed with qualification</td><td align="center" valign="bottom">66 (20.8)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Service or shop sales worker</td><td align="center" valign="bottom">133 (41.8)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Elementary occupation</td><td align="center" valign="bottom">62 (19.5)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>Toilet facility (N, %</bold>)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Pit latrine</td><td align="center" valign="bottom">75 (23.6)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Water closet</td><td align="center" valign="bottom">243 (76.4)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>Cooking fuel (N, %)</bold><sup><xref ref-type="table-fn" rid="table1fn2">*</xref></sup></td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Smoky</td><td align="center" valign="bottom">113 (35.5)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Non-smoky</td><td align="center" valign="bottom">205 (64.5)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>Exposure to animals, yes (N, %)</bold></td><td align="center" valign="bottom">138 (43.4)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>The course of antibiotics in the past year (N, %</bold>)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="char" char="ndash" valign="bottom">1–3 courses</td><td align="center" valign="bottom">164 (50.8)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="char" char="." valign="bottom">&gt;3 courses</td><td align="center" valign="bottom">28 (8.7)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">None</td><td align="center" valign="bottom">131 (40.6)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>Last time antibiotic use (N, %</bold>)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="char" char="ndash" valign="bottom">3–6 months ago</td><td align="center" valign="bottom">44 (13.6)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="char" char="ndash" valign="bottom">6–12 months ago</td><td align="center" valign="bottom">65 (20.1)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="char" char="." valign="bottom">12 months ago,</td><td align="center" valign="bottom">83 (25.7)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">None</td><td align="center" valign="bottom">131 (40.6)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom"><bold>Access to clean water (N, %</bold>)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Tap water</td><td align="center" valign="bottom">314 (97.2)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr><tr><td align="left" valign="bottom">Well, canal or river water</td><td align="center" valign="bottom">9 (2.8)</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr></tbody></table><table-wrap-foot><fn><p>Comparison between characteristics of the Tanzanian and the Dutch participants was done using Chi-square and, Mann-Whitney U tests; for categorical and continuous variables respectively.</p></fn><fn id="table1fn2"><label>*</label><p>categories of cooking fuel include firewood, charcoal or kerosene (smoky), or gas and electrical (non-smoky).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>Differences in inflammatory proteome between Tanzanians and Dutch</title><p>The inflammatory proteome was measured simultaneously in samples from the Tanzanian and Dutch participants using the Olink ‘inflammation’ panel, which targets 92 cytokines, chemokines and other inflammation and metabolism-related proteins (Olink Proteomics AB, Uppsala, Sweden). Relative protein concentrations are reported as normalized protein expression (NPX) units, which are on a Log2 scale. Eighteen proteins were excluded from further analysis because their value was below the lower limit of detection in more than 25% of samples in both cohorts (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Principal component analysis (PCA) of the remaining 74 proteins revealed a clear separation between Tanzanian and Dutch samples (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). A volcano plot of differentially expressed proteins (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) showed that 35 (47%) proteins were significantly higher in the Tanzanians and 20 (27%) lower at an FDR p&lt;0.05, with correction for age and sex and BMI. The most prominently (fold change (FC)) upregulated proteins were two regulators of metabolism: the mTOR substrate and translational repressor 4E-BP1 (log<sub>2</sub> FC 1.9; FDR p=1.3 × 10<sup>–60</sup>) and FGF21 (fibroblast growth factor 21; log<sub>2</sub> FC 1.3; p=1.3 × 10<sup>–30</sup>), a hormone produced by the liver that functions as a major regulator of glucose and lipid homeostasis. Obesity and excess carbohydrate and/or insufficient protein intake were reported to increase FGF21 concentrations (<xref ref-type="bibr" rid="bib17">Hill et al., 2018</xref>). Other prominently upregulated proteins in the Tanzanians were interleukin (IL)–17 A (log<sub>2</sub> FC 0.7; p=9.6 × 10<sup>–34</sup>) and IL-17C (log<sub>2</sub> FC 0.7; p=1.1 × 10<sup>–74</sup>), and the CC-chemokine family members CCL11/eotaxin (eosinophil chemoattractant; log<sub>2</sub> FC 0.7; p=7.3 × 10<sup>–63</sup>), CCL3/MIP-1α (macrophage inflammatory protein-1α; log<sub>2</sub> FC 0.6; p=5.6 × 10<sup>–10</sup>), CCL7/MCP3 (monocyte chemotactic protein 3; log<sub>2</sub> FC 0.6; p=7.4 × 10<sup>–42</sup>) and CCL8/MCP2 (log<sub>2</sub> FC 0.5; p=8.4 × 10<sup>–23</sup>). The cytokines Tumour Necrosis Factor (TNF), IL-6, IL-10, and IL-18, as well as oncostatin-M (OSM) and adenosine deaminase (ADA) were also significantly higher in the Tanzanians.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Differentially expressed inflammatory protein profiles among Dutch and Tanzanian participants.</title><p>(<bold>A</bold>) Principal component analysis depicting the sample distribution of Dutch (N=416) vs. Tanzanian (N=318) healthy individuals across PC1 and PC2, indicating significant differences in the inflammatory protein profiles of the two cohorts. (<bold>B</bold>) Volcano plot showing differentially expressed proteins (DEPs) between the Dutch and Tanzanian cohorts (Dutch cohort; N=74 and Tanzanian cohort; N=72 inflammatory proteins; analyzed by Limma, linear models for microarray data, R package). The x-axis shows the Log2 fold change (Log2 FC) of the normalized protein expression (NPX), while the y-axis shows the -Log10 of the adjusted p-values (FDR &lt;0.05); dotted lines represent the cut-off value Log2FC &lt; 0.5 and&gt; 0.5. (<bold>C</bold>) Violin plots showing concentrations of circulating adipokines and inflammatory cytokines in the Dutch and Tanzanian participants (data previously reported (<xref ref-type="bibr" rid="bib36">Temba et al., 2022</xref>); differences analyzed by linear regression with age, sex and BMI as covariates). Results were declared significant after correcting for multiple testing using False discovered rate (FDR). AAT; alpha-1 antitrypsin; BMI; Body Mass Index.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82297-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Histograms and pie charts showing the distribution of cohorts characteristics comparing Tanzanian and Dutch samples.</title><p>Histograms (<bold>A</bold>) and (<bold>B</bold>) show the age and BMI distributions of Tanzanians and Dutch subjects, respectively A pie chart comparing the gender distributions of Tanzanians and the Dutch cohort. This figure is related to the data displayed on <xref ref-type="table" rid="table1">Table 1</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82297-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Schematic diagram showing the sample pre-processing according to the measured inflammatory protein in both cohorts.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82297-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Scatter plot showing the association of plasma concentration of leptin with BMI in Tanzanian females compared to Dutch females.</title><p>The comparison was performed using linear regression (unadjusted) on the inversed ranked based values of leptin concentration.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82297-fig1-figsupp3-v2.tif"/></fig></fig-group><p>The most prominently downregulated proteins in Tanzanians were ST1A1 (sulfotransferase 1A1; log<sub>2</sub> FC –0.8; p=2.2 × 10<sup>–16</sup>) and AXIN1 (axis inhibition protein 1; log<sub>2</sub> FC –0.7; p=6.5 × 10<sup>–18</sup>). ST1A1 is a cytosolic sulfotransferase that catalyzes the sulfonation of endogenous and exogenous compounds (<xref ref-type="bibr" rid="bib39">Wang et al., 2016</xref>). AXIN1 is a negative regulator of the Wnt/β-catenin signaling pathway (<xref ref-type="bibr" rid="bib20">Kikuchi, 1999</xref>). This pathway is increasingly recognized to play an important role in inflammatory diseases, diabetes and cancer (<xref ref-type="bibr" rid="bib18">Jridi et al., 2020</xref>; <xref ref-type="bibr" rid="bib9">Das et al., 2021</xref>). Conversely, CDCP1 (CUB domain-containing protein 1), a transmembrane receptor that is a Wnt signaling promoter (<xref ref-type="bibr" rid="bib14">He et al., 2020</xref>) was significantly up-regulated (log<sub>2</sub> FC 0.7; p=1.8 × 10<sup>–61</sup>) in the Tanzanian cohort, suggesting enhanced activity of the Wnt/β-catenin signaling pathway in the Tanzanian participants. Finally, Tanzanians had lower levels of the CXC chemokine family members CXCL1, CXCL5, CXCL6, and CXCL8 (IL8). These chemokines mediate among others neutrophil trafficking (<xref ref-type="bibr" rid="bib30">Palomino and Marti, 2015</xref>).</p><p>The Olink platform used in this study does not contain adipocytokines and provides relative, rather than absolute, protein concentrations. Therefore, we measured absolute concentrations of a selection of cytokines using an ELLA microfluidics platform, and concentrations of adipocytokines by ELISA. The data have been reported previously (<xref ref-type="bibr" rid="bib36">Temba et al., 2022</xref>), and confirm that Tanzanian participants have significantly higher plasma concentrations of IL-1 receptor antagonist (IL-1Ra), IL-6, and IL-18, together with significantly higher leptin and lower adiponectin concentrations than Dutch participants after correcting for age, sex, and BMI (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). In addition, Tanzanian females regardless of BMI had higher plasma concentrations of leptin compared to Dutch females (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>) in line with the previous findings (<xref ref-type="bibr" rid="bib1">Abbas et al., 2004</xref>). There were no significant differences in plasma concentrations of resistin and alpha-1 antitrypsin (AAT).</p><p>In a previous study in the same cohort, we identified different genetic loci that were associated with whole-blood cytokine responses to a variety of microbial and synthetic ligands (<xref ref-type="bibr" rid="bib5">Boahen et al., 2022</xref>). We assessed whether these genetic variants were also associated with plasma protein levels. We utilized the top six independent SNP-cytokine response loci and performed matrix pQTL analysis. Different associations were identified, but none reached genome-wide (p=5 × 10<sup>–8</sup>) or suggestive (p=5 × 10<sup>–6</sup>) significance (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref><bold>;</bold> P-value unadjusted).</p></sec><sec id="s2-3"><title>Associations between inflammation-related proteins and intrinsic and environmental factors</title><p>Next, we investigated associations between the inflammation-related proteins with host intrinsic factors such as age and sex, BMI and environmental exposures relevant to the Tanzanian setting. The analyses were variously corrected for age, sex and BMI to assess the impact of one specific factor. In high-income countries, age is a potent driver of immune variation with a shift toward a pro-inflammatory state (<xref ref-type="bibr" rid="bib7">Brüünsgaard and Pedersen, 2003</xref>, <xref ref-type="bibr" rid="bib11">Ferrucci et al., 2005</xref>). In the Dutch participants, advancing age was indeed associated with an increase in inflammation-related proteins, including inflammatory cytokines (IL-6, IL-7, IL-18), IL-15RA, monocyte chemoattractant proteins (MCP2-4), matrix metalloprotease1 (MMP1), the chemokine IL-8 and hepatocyte growth factor (HGF). In contrast, these significant associations were largely absent in the Tanzanians (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). An exception was a strong significant positive association of advancing age with CDCP1, CCL11, and CCL25, which was also observed in the Dutch cohort. Overall, these results show that the association between advancing age and inflammatory markers is much weaker in Tanzanians.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Associations of age, BMI, sex and seasonality with inflammatory proteins in Dutch and Tanzanian participants.</title><p>(<bold>A</bold>) Heat map illustrating the regression beta-coefficient of plasma inflammatory proteins with host and environmental factors in the Dutch and Tanzanian cohorts. Red and turquoise indicate higher and lower concentrations of inflammatory proteins associated with seasonality, higher BMI, female sex, and advanced age in the Dutch cohort, and with urban living, rainy season, higher BMI, female sex, and advanced age in the Tanzanian cohort, respectively. p-Values of the significant associations are depicted, and the results were declared significant after correcting for multiple testing using the False discovered rate (FDR); p-value &lt;0.05(*), &lt;0.005(**), and &lt;0.0001(***). (<bold>B</bold>) Four-quadrant plot depicting the association between the inflammatory protein expression with either age, sex, or BMI in the Dutch and Tanzania cohorts related to panel A.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82297-fig2-v2.tif"/></fig><p>Females in both cohorts overall had lower concentrations of inflammatory proteins than males (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), which is consistent with our earlier findings that females had lower ex vivo cytokine responses (<xref ref-type="bibr" rid="bib35">Temba et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Ter Horst et al., 2016</xref>). Results also showed that Tanzanian females had significantly higher concentrations of TNF-beta (TNFB), IL12-beta and CCL28 than Tanzanian males.</p><p>Finally, since environmental exposures are potential drivers of inflammation, we determined the relationship between relevant exposures for Tanzanians and the proteome. Such exposures included type of toilet, exposure to wood smoke for cooking, farm-animal exposure, access to clean water, previous infections and prior use of antibiotics (<xref ref-type="table" rid="table1">Table 1</xref>). Our results did not show a significant association between inflammatory proteins with one of these exposures.</p></sec><sec id="s2-4"><title>Associations with food-derived metabolites and dietary habits</title><p>We recently reported that diet, and especially the transition between a rural traditional diet to an urban Western-type diet, had a major influence on ex vivo cytokine immune responses in the Tanzanian cohort (<xref ref-type="bibr" rid="bib35">Temba et al., 2021</xref>). We postulated that diet also explained part of the variation in inflammatory proteins. To test this hypothesis, we selected food-derived metabolites (n=288) from an untargeted plasma metabolome, as previously described (<xref ref-type="bibr" rid="bib35">Temba et al., 2021</xref>). Using these metabolites, we first performed unsupervised hierarchical clustering, which yielded two different clusters (food-metabolome clusters one and two) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). Weekly food consumption was associated with these food-metabolome clusters: participants in cluster one more frequently consumed ugali (a traditional porridge made from maize), plantain (cooking banana) and green vegetables, and less frequently rice and fried potato chips (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Next, we performed unsupervised clustering of the inflammatory proteome with age, sex, BMI, geolocation (i.e. rural vs. urban living), seasonality and the food-metabolome clusters as input variables. This analysis revealed two significant inflammatory proteome clusters: one with lower and one with higher expressed inflammatory proteins (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Participants belonging to food-metabolome cluster one (i.e. more ‘traditional’ Tanzanian diet) were overrepresented in the cluster with lower-expressed inflammatory proteins, whereas participants belonging to cluster two were overrepresented in the cluster of higher-expressed inflammatory proteins (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Other factors such as age, sex or season were not associated with the inflammatory clustering.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Associations between food-derived plasma metabolites and inflammation-associated proteins.</title><p>Unsupervised k-means clustering of individuals from the Tanzanian cohort (N=318) according to the inflammatory proteins (N=72 inflammatory proteins). Data are shown as normalized protein expression (NPX). The color code indicates the relative expression of the inflammatory protein across the samples of the two compared groups. Dark red and turquoise colors indicate higher and lower expression, respectively. Presented are annotations for age, sex, BMI, seasonality, geographical location (i.e. rural vs. urban) and food-derived metabolite cluster. Abbreviations: NXP; normalized protein expression; BMI; body mass index.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82297-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Food-metabolome clusters and their associations with weekly food consumption within the Tanzanian cohort.</title><p>(<bold>A</bold>) Heat map displaying unsupervised k-means clustering of individuals from the Tanzanian cohort (N=318) based on food-derived metabolites (N=298 food-derived metabolites). Food-derived metabolites from the untargeted plasma metabolome were clustered, which yielded two clusters (traditional Tanzanian food cluster and Western diet food cluster). Red and blue colors indicate higher and lower metabolite intensity, respectively. Presented are annotations for age, sex, BMI, and seasonality. (<bold>B</bold>) Weekly food consumption of various foods across both metabolic clusters. Differences in food consumption frequency categories were tested using the chi-squared test. The colors red and blue represent higher and lower weekly consumption frequencies of specific foods, respectively; p-values &lt;0.05 (*), &lt;0.005 (**). BMI, body mass index.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82297-fig3-figsupp1-v2.tif"/></fig></fig-group><p>Next, we performed a correlation analysis to assess the relationship between diet-related metabolites and inflammatory proteins. Results show different negative associations between plant-derived polyphenols (apigenin, naringenin, cyanidin 3-(6-caffeoyl glucoside) 5-glucoside, licoagrodin, shoyuflavone C and phenolic acids such as gallic acid) and inflammatory proteins, particularly the MCP and CXCL families (<xref ref-type="fig" rid="fig4">Figure 4</xref>). In contrast, positive associations were observed between inflammatory proteins, and especially members of the MCP and CXCL families, with plasma metabolites belonging to the following classes: carboxylic acids and derivatives (e.g. aminobutanoic acid-ABA), organooxygen compounds (for example, triose), and prenol lipids such as resveratrol 4&quot;-(6-) galloylglucoside (<xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). The detailed classifications of various diet-derived metabolites and their correlations with various inflammatory proteins are presented in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>. Overall, these findings support the notion that a traditional plant-based Tanzanian diet in healthy Tanzanians has an important impact on circulating inflammatory proteins.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Association between inflammatory proteins and food-derived metabolites in the Tanzanian cohort.</title><p>The heat map illustrates the associations between inflammatory proteins and food-derived metabolites in Tanzanian participants. The left panel displays the formulas obtained from accurate mass and natural abundance isotopic mass spectrometry data, along with the putative annotated food-derived metabolites. The β coefficients of the multiple linear regression model, including age and sex as covariates, are shown in the heat map using red and turquoise colors to indicate positive and negative correlations, respectively. Significance was determined after correcting for multiple testing using False Discovery Rate (FDR); p-value &lt;0.05(*),&lt;0.005(**), and &lt;0.0001(***).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82297-fig4-v2.tif"/></fig><p>To confirm the impact of diet on the mTORC and Wnt/β-catenin pathways in Tanzanians, we utilized preliminary data from a proof-of-concept dietary intervention study that was conducted in the same region in Tanzania (ISCRTN15619939). To validate the importance of these pathways, we analyzed data from 23 young, healthy males residing in an urban area who underwent a 2-week dietary switch from a westernized to a traditional Tanzanian, high-fiber, plant-based diet. Using the same Olink proteomics platform, we observed a significant reduction in plasma levels of proteins associated with the mTOR pathway, including 4E-BP1 (beta coeff. –1.87; p=0.003) and FGF-19 (beta coeff. –1.253; p=0.0001). Additionally, we noticed a trend towards a reduction in the Wnt/ β -catenin signaling protein AXIN1 (beta coeff. –0.555; p=0.063), while CDCP1 levels remained unchanged (beta coeff. 0.049; p=0.464).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Genetic and environmental variations, including diet, lifestyle and infectious diseases burden, are important for modulating immune responses and may result in differences in immune phenotypes across populations. Our analysis of the inflammatory proteome shows that healthy Tanzanians have a more prominent pro-inflammatory phenotype compared to healthy Dutch individuals. Among the Tanzanians, food-derived metabolites were identified as an important driver of variation in inflammation-related proteins, emphasizing the potential importance of lifestyle changes.</p><p>In the same European and African cohorts, we recently showed remarkable differences in the genetic regulation of immune responses, with ancestry-specific pathways regulating induced cytokine responses and significant enrichment of the interferon pathway in the Tanzanians (<xref ref-type="bibr" rid="bib5">Boahen et al., 2022</xref>). From a historical perspective, the natural selection of genotypes that mediate a strong inflammatory response offers an obvious advantage in areas with a high infectious diseases burden such as sub-Saharan Africa. In addition, epigenetic regulation as a conduit that mirrors environmental exposure (e.g. diet, lifestyle or exposure to infectious diseases) may also promote an inflammatory signature. However, while a strong inflammatory response can be advantageous in the host’s response against infections, it may become disadvantageous when the environment changes with a reduction in the infectious burden and a shift toward an unhealthy lifestyle. Many areas in sub-Saharan Africa are currently witnessing such changes and this is one of the important drivers of the rapid increase in non-communicable diseases and other inflammation-associated pathologies.</p><p>A healthy diet is an important component of a healthy lifestyle. In the present study, we show that Tanzanians who consumed more traditional staple foods, such as ugali (porridge made from maize or millet) or plantain, as well as green vegetables, had lower concentrations of inflammation-related proteins. We also observed several significant associations between food-derived metabolites and inflammatory proteins. Specifically, plant-derived polyphenols were negatively associated with members of the MCP and CXCL families. Especially gallic acid, a natural phenic acid with different health benefits, which is present in mangos and other edible plants (<xref ref-type="bibr" rid="bib21">Kim et al., 2021</xref>), had different negative associations with immune-derived proteins. These data confirm our earlier findings that diet has an important impact on cytokine responses (<xref ref-type="bibr" rid="bib35">Temba et al., 2021</xref>) as well as plasmatic coagulation (<xref ref-type="bibr" rid="bib36">Temba et al., 2022</xref>). Traditional foods, particularly plant-based diets, are increasingly recognized for their cardiovascular health benefits (<xref ref-type="bibr" rid="bib16">Hemler and Hu, 2019</xref>), and our findings support the notion that promoting traditional diets may be a viable public health strategy for curbing the NCDs epidemic. Other environmental exposures may potentially confound the diet-inflammation associations, for example, individuals with a traditional diet may also use more frequently a pit latrine or smoky fuels and may have more infections, but we found no significant associations between inflammatory proteins and any of these other environmental exposures.</p><p>An interesting observation was the limited number of associations between advancing age and inflammation-related proteins in the Tanzanians. In historically wealthy countries, aging is associated with a blunted response of immune cells to stimulation, while having a chronic low-inflammation state (<xref ref-type="bibr" rid="bib41">Yashin and Jazwinski, 2014</xref>; <xref ref-type="bibr" rid="bib23">Liberale et al., 2020</xref>), as also observed in Dutch in this study. Cytokine responses decline in the Tanzanians with advancing age (<xref ref-type="bibr" rid="bib35">Temba et al., 2021</xref>), similar to Europeans, but the reasons why systemic inflammation does not increase remain uncertain. Possible explanations are the already present inflammatory signature at a younger age, possibly because of higher cumulative exposure to infections or other environmental insults, or that older participants in Tanzania manage to control the inflammatory state by a healthier lifestyle.</p><p>The two most upregulated proteins in the Tanzanians, 4E-BP1 and FGF21, are regulators of metabolism. FGF21 has received much attention recently as an endocrine regulator of glucose, lipid, and energy metabolism (<xref ref-type="bibr" rid="bib17">Hill et al., 2018</xref>). FGF21 is an insulin sensitizer, and its secretion is increased by a high intake of carbohydrates and low dietary protein intake (<xref ref-type="bibr" rid="bib27">Maekawa et al., 2017</xref>; <xref ref-type="bibr" rid="bib25">Lundsgaard et al., 2017</xref>). FGF21 inhibits age-associated metabolic syndrome and protects against diabetic cardiomyopathy (<xref ref-type="bibr" rid="bib40">Yan et al., 2021</xref>). FGF21, therefore, acts differently from classic energy balance signals like leptin (<xref ref-type="bibr" rid="bib17">Hill et al., 2018</xref>). Traditional Tanzanian diets are high in carbohydrates and low in proteins, which may explain the high FGF21 among the Tanzanians. FGF21 was also reported to be higher in obesity (<xref ref-type="bibr" rid="bib42">Zhang et al., 2008</xref>), but we did not find an association with BMI. Tanzanians also had higher leptin and lower adiponectin concentrations than the Dutch. This is in line with the results of an earlier study among non-obese and obese subjects with type 2 diabetes in Tanzania and Sweden, which showed that leptin concentrations were 50% higher in the Tanzanians (<xref ref-type="bibr" rid="bib1">Abbas et al., 2004</xref>). This supports the importance of potential ethnic differences in metabolic profiles and adipocytokines (<xref ref-type="bibr" rid="bib28">Mente et al., 2010</xref>). To our knowledge, this study is the first to compare FGF21 levels between healthy individuals from sub-Saharan Africa and Europe.</p><p>Another interesting finding was the significant differences in CDCP1 and AXIN1, pointing towards an enhanced activity of the Wnt/β-catenin pathway in the Tanzanians. The Wnt/β-catenin pathway is a key regulator of inflammation, playing a role in both the inflammatory and anti-inflammatory pathways (<xref ref-type="bibr" rid="bib26">Ma and Hottiger, 2016</xref>). Dysregulated activation of the Wnt/β-catenin pathway is increasingly recognized to play a role in the pathogenesis of chronic inflammatory diseases, metabolic inflammatory diseases and cancer (<xref ref-type="bibr" rid="bib18">Jridi et al., 2020</xref>). Mice fed on a high-fat Western-type diet expressed high concentrations of Wnt2 protein in atherosclerotic lesions, suggesting that the Wnt/β-catenin pathway also contributes to atherosclerosis (<xref ref-type="bibr" rid="bib43">Zhang et al., 2021</xref>).</p><p>The resolution of inflammation is typically coordinated by key lipids, proteins, and peptides (such as annexin, lipoxins, and resolvins) (<xref ref-type="bibr" rid="bib15">Headland and Norling, 2015</xref>). It would be interesting to examine whether a decrease in the production of these endogenous mediators by immune cells could potentially contribute to the pro-inflammatory phenotype observed in the Tanzanians.</p><p>To summarize, our findings reveal significant differences in inflammatory and metabolic proteins and pathways between healthy individuals living in East Africa and individuals living in Western Europe. This is especially important in light of the current epidemiological transition and lifestyle changes in sub-Saharan Africa, which coincides with a sharp increase in non-communicable diseases in the region. Our study also endorses the importance of including underrepresented populations in systems-immunology studies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Study design and population</title><p>The present study used samples from two cross-sectional cohorts of healthy volunteers: the 300-Tanzania-FG (300TZFG) and the Dutch 500FG. Both cohorts were enrolled within the Human Functional Genomics Project (<ext-link ext-link-type="uri" xlink:href="https://www.humanfunctionalgenomics.org">https://www.humanfunctionalgenomics.org</ext-link>). The demographic characteristics of both cohorts have been described previously (<xref ref-type="bibr" rid="bib35">Temba et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Ter Horst et al., 2016</xref>). Briefly, the 300TZFG cohort consists of 323 healthy Tanzanian individuals aged between 18 and 65 years residing in the Kilimanjaro region in Northern Tanzania. The cohort was enrolled between March and December 2017. Exclusion criteria were participants with any acute or chronic disease, use of antibiotics or anti-malaria medication in the three months before blood sampling, tuberculosis in the past year, a blood pressure ≤90/60 mmHg or ≥140/90 mmHg, or random blood glucose &gt;8.0 mmol/L. Pregnant, postpartum, or breastfeeding females were excluded. The 500FG cohort consists of 534 Dutch individuals of Western-European background, aged 18 years and older. Data was collected between August 2013 and December 2014 at the Radboud university medical center (Radboudumc) in the Netherlands. Exclusion criteria were: the use of any medication in the past month and acute or chronic diseases at the time of blood sampling. Pregnant, postpartum, or breastfeeding females were excluded.</p></sec><sec id="s4-2"><title>Sample collection and preparation</title><p>The current study is part of the Human Functional Genomics Project (HFGP; <ext-link ext-link-type="uri" xlink:href="http://humanfunctionalgenomics.org/">humanfunctionalgenomics.org</ext-link>), which employs standardized procedures for sample collection, handling, and pre-processing. Blood was obtained in the morning via antecubital puncture into ethylenediaminetetraacetic acid (EDTA) tubes (Monoject; Covidien, Ireland). Within two to three hours after blood collection, plasma was collected by centrifugation at 3800 rpm for 8 min at room temperature. The obtained plasma were stored at −80 °C, as recommended by the ISBER biobanking organization (<xref ref-type="bibr" rid="bib13">Garcia et al., 2014</xref>). Plasma samples for the Tanzania cohort were shipped to the Netherlands on dry ice.</p></sec><sec id="s4-3"><title>Inflammatory proteome</title><p>Plasma proteins were measured with the Olink 92 Inflammation panel using proximity extension technology (Olink Proteomics AB, Uppsala, Sweden) (<xref ref-type="bibr" rid="bib2">Assarsson et al., 2014</xref>). This panel includes 92 inflammation-related proteins. This assay utilizes the binding of target proteins by paired oligonucleotide antibody probes, followed by hybridization and amplification. Data are reported as normalized protein expression values (NPX), which is an arbitrary unit in a Log2 scale that is calculated from normalized Ct values. Validation data of the assay are available on the Olink website (<ext-link ext-link-type="uri" xlink:href="https://www.olink.com">https://www.olink.com</ext-link>). All samples were measured in the same batch in a single run. Proteins were excluded from analysis when values were both below the detection limit in more than 25% of all samples. Plasma samples from the Tanzanian and Dutch cohorts were on their first and second freeze-thawed cycles, respectively. Pre-analytical processing such as freeze-thawed cycles and storage time has limited influence on the measured proteins reported in this study (<xref ref-type="bibr" rid="bib34">Shen et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Enroth et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Lee et al., 2015</xref>).</p></sec><sec id="s4-4"><title>Measurement of the circulating inflammatory mediators</title><p>Plasma concentrations of the cytokines IL-6, IL-1β, IL-1 receptor antagonist (IL-1Ra) and IL-18 (lot number Bio-Tech/R&amp;D; SPCKC-PS-001559) and IL-18 binding protein (IL-18BPa) (lot number Bio-Tech/R&amp;D; SPCKB-PS-000502) were measured in EDTA plasma using the Simple Plex cartridges run on the Ella platform (Protein Simple, San Jose, USA) following the manufacturer’s instructions.</p></sec><sec id="s4-5"><title>Plasma metabolome</title><p>Plasma samples of the Tanzanian cohort were measured using the untargeted metabolomics workflow by General Metabolics (Boston, MA) with procedures as previously described (<xref ref-type="bibr" rid="bib12">Fuhrer et al., 2011</xref>). In short, metabolites were measured by a high throughput mass spectrometry technique using the Agilent Series 1100 LC pump coupled to a Gerstel MPS2 autosampler and the Agilent 6520 Series Quadrupole Time-of-flight mass spectrometer (Agilent, Santa Clara, CA). Our non-targeted high-throughput method relies on flow injection and does not involve separation of compounds based on an LC gradient. This is because many different species would be fragmented simultaneously. Historically, the decision to collect high-accuracy flow injection has been a technological trade-off to enable efficient analysis of large cohorts. Therefore, metabolites detected in the high-throughput non-targeted metabolomics screening method, which enables the screening of these large cohorts for metabolomic feature patterns, are based on accurate mass (approximately 1 ppm accuracy) and natural isotope detection consistent with the assigned formulae; final assignments are pending validation with LC-MS/MS. For this study, the MS spectra files (accessible at <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/metaboLights/MTBLS2267">http://www.ebi.ac.uk/metaboLights/MTBLS2267</ext-link>) contain 70 scans, each of which contains the full MS1 profile data from m/z 50–1050 for two subsequent injections from the same needle draw of any given sample. The analytical method and approach to data processing and annotation were previously described (<xref ref-type="bibr" rid="bib12">Fuhrer et al., 2011</xref>). The selection of food-derived metabolites was performed based on the ontology given in the HMDB (<ext-link ext-link-type="uri" xlink:href="https://www.hmdb.ca/">https://www.hmdb.ca/</ext-link>) as described previously (<xref ref-type="bibr" rid="bib35">Temba et al., 2021</xref>).</p></sec><sec id="s4-6"><title>Statistical analysis</title><p>The proteomic data from the Dutch and Tanzanian cohorts were normalized using inter-plate controls for batch variation correction and presented in the log<sub>2</sub> scale. Normalizing for batch effects was done using pooled plasma standards on all plates. Eight samples of plasma pool controls were measured in each cohort (two per plate, a total of 4 plates per cohort). We performed bridging normalization based on median differences between plasma pool controls in the 300TZFG and 500FG cohorts. The following steps were applied for each protein: (1) Determine the median value from the eight bridging samples for each protein in the 300TZFG and 500FG cohort. (2) Calculate the median differences (300TZFG-500FG) as median differences X. (3) Take the NXP values of each protein in the 300TZFG cohort and subtract the median difference (the X value). This created a normalized data set for the 300TZFG cohort.</p><p>Data values below the limit of detection (LOD) were handled using the actual measured values to increase the statistical power and give a complete data distribution. Outliers detection were done using principal component analysis (PCA) in which data points that fall in more than 3 standard deviations from the mean of principal component one (PC1) and two (PC2) were excluded. This pre-analytical process led to exclusion of 12 participants (N=7 Dutch and N=5 Tanzanians) as potential outliers. Proteins with &gt;25% data values below LOD in both cohorts were excluded (N=18 in the Duch and N=20 in the Tanzania cohorts), leaving 74 and 72 inflammatory proteins for the downstream data analysis in the Dutch and Tanzanian cohorts respectively. In total, 416 Dutch and 318 Tanzania participants were available after the pre-analytical process. Details of preanalytical steps for both cohorts are described in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</p><p>To analyze the similarities and dissimilarities between the samples, unsupervised PCA was performed using 'prcomp' function in R package. Heatmap of unsupervised hierarchical clustering (k-nearest neighbors with 100 repetitions) of the samples was generated using 'ComplexHeatmap' R package by calculating the matrix of Euclidean distances from the log<sub>2</sub> NPX value. Limma (linear models for microarray data) R package was used for differential expression analysis of plasma inflammatory proteins between cohorts. Proteins with adjusted P-value (FDR)&lt;0.05 were selected as significantly differentially expressed (DE). Proteins with a positive and negative value of log<sub>2</sub>-fold-change were considered as upregulated and downregulated, respectively.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Supervision, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Ethical statementThe study was approved by the Ethical Committee of the Kilimanjaro Christian Medical University College (CRERC) (No 2443) and the National Institute for Medical Research (NIMR/HQ/R.8a/Vol. IX/2290 and NIMR/HQ/R.8a/Vol.IX/3318) in Tanzania. The 500FG cohort study was approved by the Ethical Committee of the Radboud University Medical Centre Nijmegen, the Netherlands (NL42561.091.12, 2012/550). Subject recruitment and experimental procedures were conducted according to the principles mentioned in the Declaration of Helsinki. Written informed consent was obtained from all subjects.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>The table shows the top SNPs that were independently associated with ex vivo cytokine (<xref ref-type="bibr" rid="bib5">Boahen et al., 2022</xref>) and its correlation with the 74 inflammatory proteins measured in the same cohort.</title><p>P- value unadjusted.</p></caption><media xlink:href="elife-82297-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>The table summarizes the analyzed data on the differentially expressed inflammatory protein among Dutch and Tanzanian participants.</title><p>This table relates to the data displayed in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p></caption><media xlink:href="elife-82297-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>The table shows the analyzed data on the associations between food-derived plasma metabolites and inflammation-associated proteins.</title><p>This table is related to the data displayed in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></caption><media xlink:href="elife-82297-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>The table displays data from the multivariate linear regression analysis between metabolites and protein expression concentrations in the Tanzanian cohort.</title><p>This table is related to the data presented in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p></caption><media xlink:href="elife-82297-supp4-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-82297-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Normalized protein expression (NPX) units (log2) of the inflammatory proteins in the Tanzanian and Dutch participants.</title></caption><media xlink:href="elife-82297-data1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Anonymized metadata of the Tanzanian participants and the circulating inflammation markers are available in an open access registry (DANS registry; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17026/dans-xgx-zuht">https://doi.org/10.17026/dans-xgx-zuht</ext-link>). Untargeted plasma metabolome data have been deposited to the EMBL-EBI MetaboLights database (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/metabolights/">http://www.ebi.ac.uk/metabolights/</ext-link>) with study identifier MTBLS2267. The source data of the proteomics analysis are provided in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>. Publicly available databases used for this study include KEGG (<ext-link ext-link-type="uri" xlink:href="https://www.genome.jp/kegg/">https://www.genome.jp/kegg/</ext-link>), HMDB (<ext-link ext-link-type="uri" xlink:href="https://www.hmdb.ca/">https://www.hmdb.ca/</ext-link>) and ChEBI (<ext-link ext-link-type="uri" xlink:href="https://ebi.ac.uk/chebi/">https://ebi.ac.uk/chebi/</ext-link>). All other data is available in the main text and supplementary materials.</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>de Mast</surname><given-names>Q</given-names></name><name><surname>Temba</surname><given-names>GS</given-names></name><name><surname>Kullaya</surname><given-names>V</given-names></name><name><surname>Pecht</surname><given-names>T</given-names></name><name><surname>Mmbaga</surname><given-names>BT</given-names></name><name><surname>Aschenbrenner</surname><given-names>AC</given-names></name><name><surname>Ulas</surname><given-names>T</given-names></name><name><surname>Kibiki</surname><given-names>G</given-names></name><name><surname>Lyamuya</surname><given-names>F</given-names></name><name><surname>Boahen</surname><given-names>CK</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes</data-title><source>EBL MetaboLights</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/metabolights/editor/MTBLS2267">MTBLS2267</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>de Mast</surname><given-names>Q</given-names></name><name><surname>Temba</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Human functional genomics in healthy Tanzania individuals: A system biology approach in understanding individual variations in immune response</data-title><source>DANS</source><pub-id pub-id-type="doi">10.17026/dans-xgx-zuht</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors wish to express their gratitude to all volunteers in the Human Functional Genomics in Tanzania and Dutch cohorts for their participation. We would like to thank J Njau, J Kwayu, and E Kimaro for assistance with sample collection, H Lemmers, and H Toenhake-Dijkstra for assistance with laboratory analysis, and M Miclaus for assistance with pre-processing metabolome data. This study was funded by the following grants: the European Union’s Horizon 2020 Research and Innovation Program under the ERA-Net Cofund action no. 727565; the Joint Programming Initiative, A Healthy Diet for a Healthy Life (JPI-HDHL); The Netherlands Organization for Health Research and Development (ZonMW, grant number 529051018; TransMic) awarded to MGN, QdM, DC, PL and JLS; ZonMw (the Netherlands Organization for Health Research and Development) awarded to MGN, QdM and AV; Radboud Revolving Research Funds (3R-Fund) awarded to GST; Indonesia Endowment Fund for Education (LPDP) given by the Ministry of Finance of the Republic of Indonesia awarded to NV; Spinoza Prize (NWO SPI94-212) and ERC Advanced grant (no. 833247) awarded to MGN; and the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany’s Excellence Strategy (EXC2151) 390873048 awarded to MGN and JLS.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbas</surname><given-names>Z</given-names></name><name><surname>Lutale</surname><given-names>J</given-names></name><name><surname>Ahren</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Leptin levels in obese and non-obese African and Caucasian subjects with type 2 diabetes</article-title><source>International Journal of Endocrinology and Metabolism</source><volume>2</volume><fpage>61</fpage><lpage>65</lpage></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assarsson</surname><given-names>E</given-names></name><name><surname>Lundberg</surname><given-names>M</given-names></name><name><surname>Holmquist</surname><given-names>G</given-names></name><name><surname>Björkesten</surname><given-names>J</given-names></name><name><surname>Thorsen</surname><given-names>SB</given-names></name><name><surname>Ekman</surname><given-names>D</given-names></name><name><surname>Eriksson</surname><given-names>A</given-names></name><name><surname>Rennel Dickens</surname><given-names>E</given-names></name><name><surname>Ohlsson</surname><given-names>S</given-names></name><name><surname>Edfeldt</surname><given-names>G</given-names></name><name><surname>Andersson</surname><given-names>A-C</given-names></name><name><surname>Lindstedt</surname><given-names>P</given-names></name><name><surname>Stenvang</surname><given-names>J</given-names></name><name><surname>Gullberg</surname><given-names>M</given-names></name><name><surname>Fredriksson</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e95192</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0095192</pub-id><pub-id pub-id-type="pmid">24755770</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaglehole</surname><given-names>R</given-names></name><name><surname>Bonita</surname><given-names>R</given-names></name><name><surname>Horton</surname><given-names>R</given-names></name><name><surname>Adams</surname><given-names>C</given-names></name><name><surname>Alleyne</surname><given-names>G</given-names></name><name><surname>Asaria</surname><given-names>P</given-names></name><name><surname>Baugh</surname><given-names>V</given-names></name><name><surname>Bekedam</surname><given-names>H</given-names></name><name><surname>Billo</surname><given-names>N</given-names></name><name><surname>Casswell</surname><given-names>S</given-names></name><name><surname>Cecchini</surname><given-names>M</given-names></name><name><surname>Colagiuri</surname><given-names>R</given-names></name><name><surname>Colagiuri</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name><name><surname>Ebrahim</surname><given-names>S</given-names></name><name><surname>Engelgau</surname><given-names>M</given-names></name><name><surname>Galea</surname><given-names>G</given-names></name><name><surname>Gaziano</surname><given-names>T</given-names></name><name><surname>Geneau</surname><given-names>R</given-names></name><name><surname>Haines</surname><given-names>A</given-names></name><name><surname>Hospedales</surname><given-names>J</given-names></name><name><surname>Jha</surname><given-names>P</given-names></name><name><surname>Keeling</surname><given-names>A</given-names></name><name><surname>Leeder</surname><given-names>S</given-names></name><name><surname>Lincoln</surname><given-names>P</given-names></name><name><surname>McKee</surname><given-names>M</given-names></name><name><surname>Mackay</surname><given-names>J</given-names></name><name><surname>Magnusson</surname><given-names>R</given-names></name><name><surname>Moodie</surname><given-names>R</given-names></name><name><surname>Mwatsama</surname><given-names>M</given-names></name><name><surname>Nishtar</surname><given-names>S</given-names></name><name><surname>Norrving</surname><given-names>B</given-names></name><name><surname>Patterson</surname><given-names>D</given-names></name><name><surname>Piot</surname><given-names>P</given-names></name><name><surname>Ralston</surname><given-names>J</given-names></name><name><surname>Rani</surname><given-names>M</given-names></name><name><surname>Reddy</surname><given-names>KS</given-names></name><name><surname>Sassi</surname><given-names>F</given-names></name><name><surname>Sheron</surname><given-names>N</given-names></name><name><surname>Stuckler</surname><given-names>D</given-names></name><name><surname>Suh</surname><given-names>I</given-names></name><name><surname>Torode</surname><given-names>J</given-names></name><name><surname>Varghese</surname><given-names>C</given-names></name><name><surname>Watt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Priority actions for the non-communicable disease crisis</article-title><source>The Lancet</source><volume>377</volume><fpage>1438</fpage><lpage>1447</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)60393-0</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickler</surname><given-names>SW</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Amin</surname><given-names>S</given-names></name><name><surname>Halbach</surname><given-names>J</given-names></name><name><surname>Lizardo</surname><given-names>R</given-names></name><name><surname>Cauvi</surname><given-names>DM</given-names></name><name><surname>De Maio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Urbanization in sub-Saharan Africa: Declining rates of chronic and recurrent infection and their possible role in the origins of non-communicable diseases</article-title><source>World Journal of Surgery</source><volume>42</volume><fpage>1617</fpage><lpage>1628</lpage><pub-id pub-id-type="doi">10.1007/s00268-017-4389-5</pub-id><pub-id pub-id-type="pmid">29234849</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boahen</surname><given-names>CK</given-names></name><name><surname>Temba</surname><given-names>GS</given-names></name><name><surname>Kullaya</surname><given-names>VI</given-names></name><name><surname>Matzaraki</surname><given-names>V</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Kibiki</surname><given-names>G</given-names></name><name><surname>Mmbaga</surname><given-names>BT</given-names></name><name><surname>van der Ven</surname><given-names>A</given-names></name><name><surname>de Mast</surname><given-names>Q</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A functional genomics approach in Tanzanian population identifies distinct genetic regulators of cytokine production compared to European population</article-title><source>American Journal of Human Genetics</source><volume>109</volume><fpage>471</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2022.01.014</pub-id><pub-id pub-id-type="pmid">35167808</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodin</surname><given-names>P</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human immune system variation</article-title><source>Nature Reviews. Immunology</source><volume>17</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.125</pub-id><pub-id pub-id-type="pmid">27916977</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brüünsgaard</surname><given-names>H</given-names></name><name><surname>Pedersen</surname><given-names>BK</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Age-related inflammatory cytokines and disease</article-title><source>Immunology and Allergy Clinics of North America</source><volume>23</volume><fpage>15</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/s0889-8561(02)00056-5</pub-id><pub-id pub-id-type="pmid">12645876</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Park</surname><given-names>SM</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Shin</surname><given-names>CM</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Jung</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells</article-title><source>Carcinogenesis</source><volume>36</volume><fpage>553</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgv022</pub-id><pub-id pub-id-type="pmid">25784376</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>B</given-names></name><name><surname>Das</surname><given-names>M</given-names></name><name><surname>Kalita</surname><given-names>A</given-names></name><name><surname>Baro</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The role of Wnt pathway in obesity induced inflammation and diabetes: a review</article-title><source>Journal of Diabetes &amp; Metabolic Disorders</source><volume>20</volume><fpage>1871</fpage><lpage>1882</lpage><pub-id pub-id-type="doi">10.1007/s40200-021-00862-8</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enroth</surname><given-names>S</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Grankvist</surname><given-names>K</given-names></name><name><surname>Gyllensten</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Effects of long-term storage time and original sampling month on biobank plasma protein concentrations</article-title><source>EBioMedicine</source><volume>12</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2016.08.038</pub-id><pub-id pub-id-type="pmid">27596149</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Corsi</surname><given-names>A</given-names></name><name><surname>Lauretani</surname><given-names>F</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Bartali</surname><given-names>B</given-names></name><name><surname>Taub</surname><given-names>DD</given-names></name><name><surname>Guralnik</surname><given-names>JM</given-names></name><name><surname>Longo</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The origins of age-related proinflammatory state</article-title><source>Blood</source><volume>105</volume><fpage>2294</fpage><lpage>2299</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-07-2599</pub-id><pub-id pub-id-type="pmid">15572589</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrer</surname><given-names>T</given-names></name><name><surname>Heer</surname><given-names>D</given-names></name><name><surname>Begemann</surname><given-names>B</given-names></name><name><surname>Zamboni</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry</article-title><source>Analytical Chemistry</source><volume>83</volume><fpage>7074</fpage><lpage>7080</lpage><pub-id pub-id-type="doi">10.1021/ac201267k</pub-id><pub-id pub-id-type="pmid">21830798</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>DL</given-names></name><name><surname>Bracci</surname><given-names>PM</given-names></name><name><surname>Guevarra</surname><given-names>DM</given-names></name><name><surname>Sieffert</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>International Society for Biological and Environmental Repositories (ISBER) tools for the biobanking community</article-title><source>Biopreservation and Biobanking</source><volume>12</volume><fpage>435</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1089/bio.2014.1264</pub-id><pub-id pub-id-type="pmid">25496158</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Davies</surname><given-names>CM</given-names></name><name><surname>Harrington</surname><given-names>BS</given-names></name><name><surname>Hellmers</surname><given-names>L</given-names></name><name><surname>Sheng</surname><given-names>Y</given-names></name><name><surname>Broomfield</surname><given-names>A</given-names></name><name><surname>McGann</surname><given-names>T</given-names></name><name><surname>Bastick</surname><given-names>K</given-names></name><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Maresh</surname><given-names>G</given-names></name><name><surname>McChesney</surname><given-names>S</given-names></name><name><surname>Yau Wong</surname><given-names>K</given-names></name><name><surname>Adams</surname><given-names>MN</given-names></name><name><surname>Sullivan</surname><given-names>RC</given-names></name><name><surname>Palmer</surname><given-names>JS</given-names></name><name><surname>Burke</surname><given-names>LJ</given-names></name><name><surname>Ewing</surname><given-names>AD</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Margolin</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Lourie</surname><given-names>R</given-names></name><name><surname>Matsika</surname><given-names>A</given-names></name><name><surname>Srinivasan</surname><given-names>B</given-names></name><name><surname>McGuckin</surname><given-names>MA</given-names></name><name><surname>Lumley</surname><given-names>JW</given-names></name><name><surname>Hooper</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin</article-title><source>Oncogene</source><volume>39</volume><fpage>219</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/s41388-019-0983-3</pub-id><pub-id pub-id-type="pmid">31471585</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Headland</surname><given-names>SE</given-names></name><name><surname>Norling</surname><given-names>LV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The resolution of inflammation: Principles and challenges</article-title><source>Seminars in Immunology</source><volume>27</volume><fpage>149</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2015.03.014</pub-id><pub-id pub-id-type="pmid">25911383</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemler</surname><given-names>EC</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Plant-based diets for cardiovascular disease prevention: all plant foods are not created equal</article-title><source>Current Atherosclerosis Reports</source><volume>21</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1007/s11883-019-0779-5</pub-id><pub-id pub-id-type="pmid">30895476</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>CM</given-names></name><name><surname>Berthoud</surname><given-names>HR</given-names></name><name><surname>Münzberg</surname><given-names>H</given-names></name><name><surname>Morrison</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Homeostatic sensing of dietary protein restriction: A case for FGF21</article-title><source>Frontiers in Neuroendocrinology</source><volume>51</volume><fpage>125</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.yfrne.2018.06.002</pub-id><pub-id pub-id-type="pmid">29890191</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jridi</surname><given-names>I</given-names></name><name><surname>Canté-Barrett</surname><given-names>K</given-names></name><name><surname>Pike-Overzet</surname><given-names>K</given-names></name><name><surname>Staal</surname><given-names>FJT</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inflammation and wnt signaling: target for immunomodulatory therapy?</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>8</volume><elocation-id>615131</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2020.615131</pub-id><pub-id pub-id-type="pmid">33614624</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>EK</given-names></name><name><surname>Kwiatkowski</surname><given-names>DP</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Natural selection and infectious disease in human populations</article-title><source>Nature Reviews. Genetics</source><volume>15</volume><fpage>379</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1038/nrg3734</pub-id><pub-id pub-id-type="pmid">24776769</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Roles of Axin in the Wnt signalling pathway</article-title><source>Cellular Signalling</source><volume>11</volume><fpage>777</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/s0898-6568(99)00054-6</pub-id><pub-id pub-id-type="pmid">10617280</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Castellon-Chicas</surname><given-names>MJ</given-names></name><name><surname>Arbizu</surname><given-names>S</given-names></name><name><surname>Talcott</surname><given-names>ST</given-names></name><name><surname>Drury</surname><given-names>NL</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Mertens-Talcott</surname><given-names>SU</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mango (<italic>Mangifera indica</italic> L.) polyphenols: anti-inflammatory intestinal microbial health benefits, and associated mechanisms of actions</article-title><source>Molecules</source><volume>26</volume><elocation-id>2732</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26092732</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Shin</surname><given-names>SY</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Effect of repeated freezing and thawing on biomarker stability in plasma and serum samples</article-title><source>Osong Public Health and Research Perspectives</source><volume>6</volume><fpage>357</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.phrp.2015.11.005</pub-id><pub-id pub-id-type="pmid">26835245</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberale</surname><given-names>L</given-names></name><name><surname>Montecucco</surname><given-names>F</given-names></name><name><surname>Tardif</surname><given-names>JC</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Camici</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease</article-title><source>European Heart Journal</source><volume>41</volume><fpage>2974</fpage><lpage>2982</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehz961</pub-id><pub-id pub-id-type="pmid">32006431</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liston</surname><given-names>A</given-names></name><name><surname>Humblet-Baron</surname><given-names>S</given-names></name><name><surname>Duffy</surname><given-names>D</given-names></name><name><surname>Goris</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Human immune diversity: from evolution to modernity</article-title><source>Nature Immunology</source><volume>22</volume><fpage>1479</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1038/s41590-021-01058-1</pub-id><pub-id pub-id-type="pmid">34795445</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundsgaard</surname><given-names>A-M</given-names></name><name><surname>Fritzen</surname><given-names>AM</given-names></name><name><surname>Sjøberg</surname><given-names>KA</given-names></name><name><surname>Myrmel</surname><given-names>LS</given-names></name><name><surname>Madsen</surname><given-names>L</given-names></name><name><surname>Wojtaszewski</surname><given-names>JFP</given-names></name><name><surname>Richter</surname><given-names>EA</given-names></name><name><surname>Kiens</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates</article-title><source>Molecular Metabolism</source><volume>6</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2016.11.001</pub-id><pub-id pub-id-type="pmid">28123934</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Hottiger</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Crosstalk between Wnt/β-catenin and NF-κB signaling pathway during inflammation</article-title><source>Frontiers in Immunology</source><volume>7</volume><elocation-id>378</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00378</pub-id><pub-id pub-id-type="pmid">27713747</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maekawa</surname><given-names>R</given-names></name><name><surname>Seino</surname><given-names>Y</given-names></name><name><surname>Ogata</surname><given-names>H</given-names></name><name><surname>Murase</surname><given-names>M</given-names></name><name><surname>Iida</surname><given-names>A</given-names></name><name><surname>Hosokawa</surname><given-names>K</given-names></name><name><surname>Joo</surname><given-names>E</given-names></name><name><surname>Harada</surname><given-names>N</given-names></name><name><surname>Tsunekawa</surname><given-names>S</given-names></name><name><surname>Hamada</surname><given-names>Y</given-names></name><name><surname>Oiso</surname><given-names>Y</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Arima</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice</article-title><source>The Journal of Nutritional Biochemistry</source><volume>49</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2017.07.010</pub-id><pub-id pub-id-type="pmid">28886439</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mente</surname><given-names>A</given-names></name><name><surname>Razak</surname><given-names>F</given-names></name><name><surname>Blankenberg</surname><given-names>S</given-names></name><name><surname>Vuksan</surname><given-names>V</given-names></name><name><surname>Davis</surname><given-names>AD</given-names></name><name><surname>Miller</surname><given-names>R</given-names></name><name><surname>Teo</surname><given-names>K</given-names></name><name><surname>Gerstein</surname><given-names>H</given-names></name><name><surname>Sharma</surname><given-names>AM</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Anand</surname><given-names>SS</given-names></name><collab>Study of the Health Assessment And Risk Evaluation</collab></person-group><year iso-8601-date="2010">2010</year><article-title>Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance</article-title><source>Diabetes Care</source><volume>33</volume><fpage>1629</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.2337/dc09-1392</pub-id><pub-id pub-id-type="pmid">20413520</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>KJ</given-names></name><name><surname>Tabas</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Macrophages in the pathogenesis of atherosclerosis</article-title><source>Cell</source><volume>145</volume><fpage>341</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.04.005</pub-id><pub-id pub-id-type="pmid">21529710</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palomino</surname><given-names>DCT</given-names></name><name><surname>Marti</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chemokines and immunity</article-title><source>Einstein</source><volume>13</volume><fpage>469</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1590/S1679-45082015RB3438</pub-id><pub-id pub-id-type="pmid">26466066</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schutte</surname><given-names>AE</given-names></name><name><surname>van Vuuren</surname><given-names>D</given-names></name><name><surname>van Rooyen</surname><given-names>JM</given-names></name><name><surname>Huisman</surname><given-names>HW</given-names></name><name><surname>Schutte</surname><given-names>R</given-names></name><name><surname>Malan</surname><given-names>L</given-names></name><name><surname>Malan</surname><given-names>NT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study</article-title><source>Journal of Human Hypertension</source><volume>20</volume><fpage>850</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1038/sj.jhh.1002065</pub-id><pub-id pub-id-type="pmid">16855625</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schutte</surname><given-names>AE</given-names></name><name><surname>Myburgh</surname><given-names>A</given-names></name><name><surname>Olsen</surname><given-names>MH</given-names></name><name><surname>Eugen-Olsen</surname><given-names>J</given-names></name><name><surname>Schutte</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study</article-title><source>Thrombosis Research</source><volume>130</volume><fpage>273</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.thromres.2011.10.034</pub-id><pub-id pub-id-type="pmid">22113150</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyedsadjadi</surname><given-names>N</given-names></name><name><surname>Grant</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The potential benefit of monitoring oxidative stress and inflammation in the prevention of non-communicable diseases (ncds)</article-title><source>Antioxidants</source><volume>10</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.3390/antiox10010015</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Q</given-names></name><name><surname>Björkesten</surname><given-names>J</given-names></name><name><surname>Galli</surname><given-names>J</given-names></name><name><surname>Ekman</surname><given-names>D</given-names></name><name><surname>Broberg</surname><given-names>J</given-names></name><name><surname>Nordberg</surname><given-names>N</given-names></name><name><surname>Tillander</surname><given-names>A</given-names></name><name><surname>Kamali-Moghaddam</surname><given-names>M</given-names></name><name><surname>Tybring</surname><given-names>G</given-names></name><name><surname>Landegren</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays</article-title><source>Clinical Chemistry and Laboratory Medicine</source><volume>56</volume><fpage>582</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1515/cclm-2017-0648</pub-id><pub-id pub-id-type="pmid">29040064</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temba</surname><given-names>GS</given-names></name><name><surname>Kullaya</surname><given-names>V</given-names></name><name><surname>Pecht</surname><given-names>T</given-names></name><name><surname>Mmbaga</surname><given-names>BT</given-names></name><name><surname>Aschenbrenner</surname><given-names>AC</given-names></name><name><surname>Ulas</surname><given-names>T</given-names></name><name><surname>Kibiki</surname><given-names>G</given-names></name><name><surname>Lyamuya</surname><given-names>F</given-names></name><name><surname>Boahen</surname><given-names>CK</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>van der Ven</surname><given-names>AJ</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>de Mast</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes</article-title><source>Nature Immunology</source><volume>22</volume><fpage>287</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1038/s41590-021-00867-8</pub-id><pub-id pub-id-type="pmid">33574617</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temba</surname><given-names>GS</given-names></name><name><surname>Vadaq</surname><given-names>N</given-names></name><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Kullaya</surname><given-names>V</given-names></name><name><surname>Huskens</surname><given-names>D</given-names></name><name><surname>Pecht</surname><given-names>T</given-names></name><name><surname>Jaeger</surname><given-names>M</given-names></name><name><surname>Boahen</surname><given-names>CK</given-names></name><name><surname>Matzaraki</surname><given-names>V</given-names></name><name><surname>Broeders</surname><given-names>W</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Faradz</surname><given-names>SMH</given-names></name><name><surname>Kibiki</surname><given-names>G</given-names></name><name><surname>Middeldorp</surname><given-names>S</given-names></name><name><surname>Cavalieri</surname><given-names>D</given-names></name><name><surname>Lionetti</surname><given-names>P</given-names></name><name><surname>de Groot</surname><given-names>PG</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>de Laat</surname><given-names>B</given-names></name><name><surname>Mmbaga</surname><given-names>BT</given-names></name><name><surname>van der Ven</surname><given-names>AJ</given-names></name><name><surname>Roest</surname><given-names>M</given-names></name><name><surname>de Mast</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non-genetic factors</article-title><source>Journal of Thrombosis and Haemostasis</source><volume>20</volume><fpage>1089</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1111/jth.15657</pub-id><pub-id pub-id-type="pmid">35102686</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ter Horst</surname><given-names>R</given-names></name><name><surname>Jaeger</surname><given-names>M</given-names></name><name><surname>Smeekens</surname><given-names>SP</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Diavatopoulos</surname><given-names>DA</given-names></name><name><surname>Jansen</surname><given-names>AFM</given-names></name><name><surname>Lemmers</surname><given-names>H</given-names></name><name><surname>Toenhake-Dijkstra</surname><given-names>H</given-names></name><name><surname>van Herwaarden</surname><given-names>AE</given-names></name><name><surname>Janssen</surname><given-names>M</given-names></name><name><surname>van der Molen</surname><given-names>RG</given-names></name><name><surname>Joosten</surname><given-names>I</given-names></name><name><surname>Sweep</surname><given-names>FCGJ</given-names></name><name><surname>Smit</surname><given-names>JW</given-names></name><name><surname>Netea-Maier</surname><given-names>RT</given-names></name><name><surname>Koenders</surname><given-names>MMJF</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Dinarello</surname><given-names>CA</given-names></name><name><surname>Pavelka</surname><given-names>N</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Notebaart</surname><given-names>RA</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Host and environmental factors influencing individual human cytokine responses</article-title><source>Cell</source><volume>167</volume><fpage>1111</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.018</pub-id><pub-id pub-id-type="pmid">27814508</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unwin</surname><given-names>N</given-names></name><name><surname>James</surname><given-names>P</given-names></name><name><surname>McLarty</surname><given-names>D</given-names></name><name><surname>Machybia</surname><given-names>H</given-names></name><name><surname>Nkulila</surname><given-names>P</given-names></name><name><surname>Tamin</surname><given-names>B</given-names></name><name><surname>Nguluma</surname><given-names>M</given-names></name><name><surname>McNally</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Rural to urban migration and changes in cardiovascular risk factors in Tanzania: a prospective cohort study</article-title><source>BMC Public Health</source><volume>10</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1186/1471-2458-10-272</pub-id><pub-id pub-id-type="pmid">20497567</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Cook</surname><given-names>I</given-names></name><name><surname>Leyh</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Design and interpretation of human sulfotransferase 1a1 assays</article-title><source>Drug Metabolism and Disposition</source><volume>44</volume><fpage>481</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1124/dmd.115.068205</pub-id><pub-id pub-id-type="pmid">26658224</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The roles and pharmacological effects of fgf21 in preventing aging-associated metabolic diseases</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>8</volume><elocation-id>655575</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2021.655575</pub-id><pub-id pub-id-type="pmid">33869312</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yashin</surname><given-names>AI</given-names></name><name><surname>Jazwinski</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Aging and health - a systems biology perspective</article-title><source>Interdiscipl Top Gerontol Basel, Karger</source><volume>40</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1159/isbn.978-3-318-02730-3</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yeung</surname><given-names>DCY</given-names></name><name><surname>Karpisek</surname><given-names>M</given-names></name><name><surname>Stejskal</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>Z-G</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Wong</surname><given-names>RLC</given-names></name><name><surname>Chow</surname><given-names>W-S</given-names></name><name><surname>Tso</surname><given-names>AWK</given-names></name><name><surname>Lam</surname><given-names>KSL</given-names></name><name><surname>Xu</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Serum fgf21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans</article-title><source>Diabetes</source><volume>57</volume><fpage>1246</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.2337/db07-1476</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Rojas</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Musich</surname><given-names>PR</given-names></name><name><surname>Gutierrez</surname><given-names>M</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Thewke</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Wnt2 contributes to the development of atherosclerosis</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>8</volume><elocation-id>751720</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2021.751720</pub-id><pub-id pub-id-type="pmid">34901211</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82297.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0176yjw32</institution-id><institution>Universidade Federal de Minas Gerais</institution></institution-wrap><country>Brazil</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.08.23.504992" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.23.504992"/></front-stub><body><p>The manuscript by Temba and colleagues describe an essential aspect of human research, i.e., the variability of different populations which have different genetic backgrounds and are exposed to different diets and environments. As most research is carried out in developed countries, we need to understand and generate background data in other populations, such as the described here in Tanzania. The fundamental findings refer to enhanced pro-inflammatory phenotype in plasma of individuals from Tanzania as compared to individuals from Holland. Food-derived metabolites were identified as a driver of variation in inflammation-related molecule expression. Whether pro-inflammatory phenotypes associate with changes in life span or risk of chronic disease and whether changes in life style will reverse this pro-inflammatory phenotype and related outcomes clearly deserve further investigation in the future.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82297.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0176yjw32</institution-id><institution>Universidade Federal de Minas Gerais</institution></institution-wrap><country>Brazil</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.23.504992">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.08.23.504992v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Differences in the inflammatory proteome of East African and Western European adults and associations with environmental and dietary factors&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Carlos Isales as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Both reviewers and I found the manuscript interesting and important. Both reviewers would like to see some validation of findings – either ex vivo, in vivo or in different populations. This may be a little beyond the scope of the current study (as it would need large patient cohorts or significant clinical studies) but needs to be discussed in some detail. Whenever possible, validation should be performed, as suggested by reviewers.</p><p>2) There is a need to clarify some relevant methodological issues.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Recommendations for the authors:</p><p>– The proteomic data were normalized for batch effect. The authors should describe in detail the batch correction method.</p><p>– The authors should correlate the inflammatory proteome with the common genetic variations described in a previous manuscript for the same cohorts (Boahen et al., 2022).</p><p>– Circulating proteins related to the mTOR pathway and metabolism, such as 4EBP1 and FGF21, were differentially regulated. Moreover, AXIN1 and CDCP1, associated with the Wnt/β-catenin pathway, were regulated. The authors should validate the differential expression of these pathways by looking at other targets in the two cohorts using orthogonal techniques.</p><p>–The dysregulation of mTOR and Wnt/β-catenin pathways should be evaluated upon food-borne metabolite treatment. This validation can be performed in ex vivo and in vivo models.</p><p>– From the Materials and methods section, the identification of metabolites was based on accurate mass. However, no fragmentation spectra were shown to validate the identity of the metabolites. Fragmentation spectra should be shown to validate the identifications of food-borne metabolites.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Overall, this is an interesting study that has potential broad impact if the findings can be reproduced in additional cohorts. I have no major concerns. The authors are correct to state that genetics and epigenetic mechanisms may play are strong role here with respect to population differences and impact on inflammatory proteins and specific metabolites.</p><p>It would be interesting to confirm these findings using additional sub-Saharan Africa cohorts in a more targeted way – for example, could lead metabolites and cytokines be measured in additional cohorts from sub-Saharan Africa?</p><p>An alternative explanation to consider here is that there is an impairment in the resolution of inflammation in the Tanzanian cohort. Resolution of inflammation is typically coordinated by key lipids, proteins and peptides (E.g. annexin, lipoxins, resolvins etc…). Could it be that there is impaired production of these endogenous mediators by immune cells in the Tanzanian cohort versus the Dutch cohort? This is speculative, but it could be mentioned as a possibility for future studies.</p><p>The selected o-link panel obviously biases the analyses towards inflammatory pathways, and it would be interesting in future to consider using a more global proteomics approach to identify alternative pathways that may be contributing factors here.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82297.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Reviewer #1 (Recommendations for the authors):</p><p>Recommendations for the authors:</p><p>– The proteomic data were normalized for batch effect. The authors should describe in detail the batch correction method.</p></disp-quote><p>We now describe the normalization for batch effect in detail in the methods section under statistical analysis, page 20; lines 320-327. Normalizing for batch effects was done using pooled plasma standards on all plates. Eight samples of plasma pool controls were measured in each cohort (two per plate, a total of 4 plates per cohort). We performed bridging normalization based on median differences between plasma pool controls in the 300TZFG and 500FG cohorts. The following steps were applied for each protein: (1) Determine the median value from the eight bridging samples for each protein in the 300TZFG and 500FG cohort. (2) Calculate the median differences (300TZFG-500FG) as median differences X. (3) Take the NXP values of each protein in the 300TZFG cohort and subtract the median difference (the X value). This created a normalized data set for the 300TZFG cohort.</p><disp-quote content-type="editor-comment"><p>– The authors should correlate the inflammatory proteome with the common genetic variations described in a previous manuscript for the same cohorts (Boahen et al., 2022).</p></disp-quote><p>We thank the reviewer for this suggestion. In our previous manuscript (Boahen et al., 2022), we studied the genetic variations of whole-blood cytokine responses to a range of microbial and synthetic ligands. We used the top six independent SNP-cytokine loci identified in this previous paper and performed matrix pQTL analysis to determine an association with the protein expression levels. As shown in the table, we found several associations, but none of these reached genome-wide (P&lt;5X10<sup>-8</sup>) or suggestive (P&lt;5X10<sup>-6</sup>) significance, possibly due to the limited sample size of our cohort.</p><p>We have included this information in the text (page 9; lines 107-112) and we included the table as a Table S1.</p><disp-quote content-type="editor-comment"><p>– Circulating proteins related to the mTOR pathway and metabolism, such as 4EBP1 and FGF21, were differentially regulated. Moreover, AXIN1 and CDCP1, associated with the Wnt/β-catenin pathway, were regulated. The authors should validate the differential expression of these pathways by looking at other targets in the two cohorts using orthogonal techniques.</p></disp-quote><p>We attempted to validate the differential expression of these proteins and pathways using whole blood transcriptomics data, but we encountered challenges with comparability between the cohorts. Therefore, we were unable to validate the differences between the Tanzanian and Dutch cohorts using orthogonal techniques. However, we were able to confirm the significance of these pathways in relation to traditional versus westernized diet, as described in the following comment.</p><disp-quote content-type="editor-comment"><p>–The dysregulation of mTOR and Wnt/β-catenin pathways should be evaluated upon food-borne metabolite treatment. This validation can be performed in ex vivo and in vivo models.</p></disp-quote><p>In response to the comment, we utilized preliminary data from a proof-of-concept dietary intervention study that was conducted in the same region in Tanzania (ISCRTN15619939). To validate the importance of these pathways, we analyzed data from 23 young, healthy males residing in an urban area who underwent a 2-week dietary switch from a westernized to a traditional Tanzanian, high-fiber, plant-based diet. Using the same Olink proteomics platform, we observed a significant reduction in plasma levels of proteins associated with the mTOR pathway, including 4E-BP1 (β coeff. -1.87; <italic>P</italic> = 0.003) and FGF-19 (β coeff. -1.253; <italic>P</italic> = 0.0001). Additionally, we noticed a trend towards a reduction in the Wnt/ β -catenin signaling protein AXIN1 (β coeff. -0.555; <italic>P</italic> = 0.063), while CDCP1 levels remained unchanged (β coeff. 0.049; <italic>P</italic> = 0.464). We have included these findings on page 12; lines 166-175.</p><disp-quote content-type="editor-comment"><p>– From the Materials and methods section, the identification of metabolites was based on accurate mass. However, no fragmentation spectra were shown to validate the identity of the metabolites. Fragmentation spectra should be shown to validate the identifications of food-borne metabolites.</p></disp-quote><p>We appreciate the reviewer's suggestion and have now provided a detailed description of the metabolite measurement method in the methods section. Our non-targeted high-throughput method relies on flow injection and does not involve separation of compounds based on an LC gradient. This is because many different species would be fragmented simultaneously. Historically, the decision to collect high-accuracy flow injection has been a technological trade-off to enable efficient analysis of large cohorts. Therefore, metabolites detected in the high-throughput non-targeted metabolomics screening method, which enables the screening of these large cohorts for metabolomic feature patterns, are based on accurate mass (approximately 1 ppm accuracy) and natural isotope detection consistent with the assigned formulae; final assignments are pending validation with LC-MS/MS. For this study, the MS spectra files (accessible at http://www.ebi.ac.uk/metaboLights/MTBLS2267) contain 70 scans, each of which contains the full MS1 profile data from m/z 50 to 1050 for two subsequent injections from the same needle draw of any given sample.</p><p>We have incorporated this information into the method section of the revised manuscript (page 19; lines 296-308), and we have updated Figure 4 to include the putatively annotated food-borne metabolites with their formulas next to them.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Overall, this is an interesting study that has potential broad impact if the findings can be reproduced in additional cohorts. I have no major concerns. The authors are correct to state that genetics and epigenetic mechanisms may play are strong role here with respect to population differences and impact on inflammatory proteins and specific metabolites.</p><p>It would be interesting to confirm these findings using additional sub-Saharan Africa cohorts in a more targeted way – for example, could lead metabolites and cytokines be measured in additional cohorts from sub-Saharan Africa?</p></disp-quote><p>We thank the reviewer for his evaluation of the manuscript and the suggestions. Regarding the validation, we refer to our response to reviewer 1 above.</p><disp-quote content-type="editor-comment"><p>An alternative explanation to consider here is that there is an impairment in the resolution of inflammation in the Tanzanian cohort. Resolution of inflammation is typically coordinated by key lipids, proteins and peptides (E.g. annexin, lipoxins, resolvins etc…). Could it be that there is impaired production of these endogenous mediators by immune cells in the Tanzanian cohort versus the Dutch cohort? This is speculative, but it could be mentioned as a possibility for future studies.</p></disp-quote><p>We appreciate the reviewer's interesting suggestion. While we do possess plasma metabolome data for both cohorts, we are unable to compare them due to the fact that they were measured in different batches. We have included this interesting hypothesis in the Discussion section (page 16; lines 243-246).</p><disp-quote content-type="editor-comment"><p>The selected o-link panel obviously biases the analyses towards inflammatory pathways, and it would be interesting in future to consider using a more global proteomics approach to identify alternative pathways that may be contributing factors here.</p></disp-quote><p>We agree with the reviewer that our analysis is restricted to inflammation-related pathways. Further proteomic panels will undoubtedly be incorporated in subsequent studies, including the dietary-intervention study mentioned above.</p></body></sub-article></article>